In the latest trading session, 0.56 million BioAge Labs Inc (NASDAQ:BIOA) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $6.12 changed hands at -$0.02 or -0.29% at last look, the market valuation stands at $219.47M. BIOA’s current price is a discount, trading about -334.97% off its 52-week high of $26.62. The share price had its 52-week low at $3.85, which suggests the last value was 37.09% up since then. When we look at BioAge Labs Inc’s average trading volume, we note the 10-day average is 2.94 million shares, with the 3-month average coming to 832.11K.

BioAge Labs Inc (NASDAQ:BIOA) trade information

Instantly BIOA was in red as seen in intraday trades today. With action 47.87%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -66.56%, with the 5-day performance at 47.87% in the green. However, in the 30-day time frame, BioAge Labs Inc (NASDAQ:BIOA) is -66.80% down. Looking at the short shares, we see there were 2.37 million shares sold at short interest cover period of 11.43 days.

The consensus price target for the stock as assigned by Wall Street analysts is 40, meaning bulls need an upside of 84.7% from its recent market value. According to analyst projections, BIOA’s forecast low is 7 with 45 as the target high. To hit the forecast high, the stock’s price needs a -635.29% plunge from its current level, while the stock would need to soar -14.38% for it to hit the projected low.

BioAge Labs Inc (NASDAQ:BIOA)’s Major holders

Among Mutual Funds, the top two as of Oct 31, 2024 were AB Cap Fd.-AB Small Cap Growth Port and Wasatch Ultra Growth Fund. With 629.52 shares estimated at $3.84 million under it, the former controlled 1.76% of total outstanding shares. On the other hand, Wasatch Ultra Growth Fund held about 0.49% of the shares, roughly 174.08 shares worth around $1.06 million.